Femke Mathot

Chapter 9 162 using human adipose-derived stem cells. Biotechnol Prog 2013: 29: 176-85. 24. Meek MF, Coert JH. US Food and Drug Administration /Conformit Europe- approved absorb- able nerve conduits for clinical repair of peripheral and cranial nerves. Ann Plast Surg 2008: 60: 466-72. 25. Rbia N, Bulstra LF, Bishop AT, van Wijnen AJ, Shin AY. A simple dynamic strategy to deliver stem cells to decellularized nerve allografts. Plast Reconstr Surg 2018. 26. Mathot F, Rbia N, Bishop AT, et al. Adhesion, distribution, and migration of differentiated and undifferentiated mesenchymal stem cells (MSCs) seeded on nerve allografts. J Plast Reconstr Aesthet Surg 2020: 73: 81-89. 27. Mathot F, Rbia N, Thaler R, et al. Introducing Human Adipose Derived Mesenchymal Stem Cells to Avance® Nerve Grafts and NeuraGen® Nerve Guides. Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS 2020: Accepted for publication. 28. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper--Excel-based tool using pair-wise correlations. Biotechnol Lett 2004: 26: 509-15. 29. Dudakovic A, Camilleri E, Riester SM, et al. High-resolution molecular validation of self-renewal and spontaneous differentiation in clinical-grade adipose-tissue derived human mesenchymal stem cells. J Cell Biochem 2014: 115: 1816-28. 30. Jesuraj NJ, Santosa KB, Macewan MR, et al. Schwann cells seeded in acellular nerve grafts improve functional recovery. MUSCLE NERVE 2014: 49: 267-76. 31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001: 25: 402-8. 32. Manni L, Rocco ML, Bianchi P, et al. Nerve growth factor: basic studies and possible therapeutic applications. Growth Factors 2013: 31: 115-22. 33. Aarao TLS, de Sousa JR, Falcao ASC, Falcao LFM, Quaresma JAS. Nerve Growth Factor and Pathogenesis of Leprosy: Review and Update. Front Immunol 2018: 9: 939. 34. Paratcha G, Ledda F. GDNF and GFRalpha: a versatile molecular complex for developing neu- rons. Trends Neurosci 2008: 31: 384-91. 35. Yamada Y, Shimizu K, Nitta A, et al. Axonal regrowth downregulates the synthesis of glial cell line-derived neurotrophic factor in the lesioned rat sciatic nerve. Neurosci Lett 2004: 364: 11-5. 36. Magill CK, Moore AM, Yan Y, et al. The differential effects of pathway- versus target-derived glial cell line-derived neurotrophic factor on peripheral nerve regeneration. J Neurosurg 2010: 113: 102-9. 37. Jin L, Jianghai C, Juan L, Hao K. Pleiotrophin and peripheral nerve injury. Neurosurg Rev 2009: 32: 387-93. 38. Blondet B, Carpentier G, Lafdil F, Courty J. Pleiotrophin cellular localization in nerve regenera- tion after peripheral nerve injury. J Histochem Cytochem 2005: 53: 971-7. 39. Ceber M, Sener U, Mihmanli A, et al. The relationship between changes in the expression of growth associated protein-43 and functional recovery of the injured inferior alveolar nerve fol- lowing transection without repair in adult rats. J Craniomaxillofac Surg 2015: 43: 1906-13. 40. Vogelin E, Baker JM, Gates J, et al. Effects of local continuous release of brain derived neuro- trophic factor (BDNF) on peripheral nerve regeneration in a rat model. Exp Neurol 2006: 199: 348-53. 41. Zagrebelsky M, Korte M. Form follows function: BDNF and its involvement in sculpting the function and structure of synapses. Neuropharmacology 2014: 76 Pt C: 628-38. 42. Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992. 43. Scherer SS, Wrabetz L. Molecular mechanisms of inherited demyelinating neuropathies. Glia 2008: 56: 1578-89. 44. Hui-Chou HG, Hashemi SS, Hoke A, Dellon AL. Clinical implications of peripheral myelin pro- tein 22 for nerve compression and neural regeneration: a review. J Reconstr Microsurg 2011: 27: